Receptor expression in orbital inflammatory syndromes and implications for targeted therapy

Tissue Antigens

Volumn 70, Issue 2, 2007, Pages 105-109

  Ho, V H ^a   Chevez Barrios, P ^b   Jorgensen, J L ^a   Silkis, R Z ^c   Esmaeli, B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

^c CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

CD20; CD25; Denileukin diftitox; Orbital inflammatory syndrome; Rituximab; Targeted therapy

Indexed keywords

CD20 ANTIGEN; CD22 ANTIGEN; CD23 ANTIGEN; CD3 ANTIGEN; CD52 ANTIGEN; DENILEUKIN DIFTITOX; INTERLEUKIN 2 RECEPTOR ALPHA; MONOCLONAL ANTIBODY; RITUXIMAB;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG TARGETING; ENDOCRINE OPHTHALMOPATHY; EOSINOPHILIC GRANULOMA; FEMALE; FOREIGN BODY REACTION; GRANULOMATOUS INFLAMMATION; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHOID HYPERPLASIA; MALE; NECROBIOTIC DISORDER; ORBIT INFLAMMATION; ORBIT PSEUDOTUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOIDOSIS; WEGENER GRANULOMATOSIS; XANTHOGRANULOMA;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; CHILD, PRESCHOOL; FEMALE; GRANULOMA, PLASMA CELL, ORBITAL; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; ORBITAL DISEASES; RETROSPECTIVE STUDIES; SYNDROME;

EID: 34347370218     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2007.00863.x     Document Type: Article

References (16)

1. Harris GJ. Idiopathic orbital inflammation: a pathogenetic construct and treatment strategy. Ophthal Plast Reconstr Surg 2006 : 22 : 79 86.
2. Cruz AAV. Orbital inflammation and infection versus neoplasia. In : Karcioglu ZA, ed. Orbital Tumors: Diagnosis and Treatment. New York : Springer, 2005, 317 28.
3. Shields JA, Shields CL, Scartozzi R. Survey of 1264 patients with orbital tumors and simulating lesions, the 2002 Montgomery Lecture, part 1. Ophthalmology 2004 : 111 : 997 1008.
4. Moon WJ, Na DG, Ryoo JW et al. Orbital lymphoma and subacute or chronic inflammatory pseudotumor; differentiation with two-phase helical computed tomography. J Comput Assist Tomogr 2003 : 27 : 510 6.
5. Ahn Yuen SJ, Rubin PAD. Idiopathic orbital inflammation; distribution, clinical features, and treatment outcome. Arch Ophthalmol 2003 : 121 : 491 9.
6. Rubin PAD, Foster S. Etiology and management of idiopathic orbital inflammation. Am J Ophthalmol 2004 : 138 : 1041 3.
7. Wilson MW, Shergy WJ, Haik BG. Infliximab in the treatment of recalcitrant idiopathic orbital inflammation. Ophthal Plast Recontr Surg 2004 : 20 : 381 3.
8. Lowen MS, Saraiva VS, Martins MC et al. Immunohistochemical profile of lymphoid lesions of the orbit. Can J Ophthalmol 2005 : 40 : 634 9.
9. Hougardy DMC, Peterson GM, Blease MD, Randal CTC. Is enough attention being given to the adverse effects of corticosteroid therapy? J Clin Pharm Ther 2000 : 25 : 227 34.
10. Henderson RA, Mossman S, Nairn N, Cheever MA. Cancer vaccines and immunotherapies: emerging perspectives. Vaccine 2005 : 23 : 2359 62.
11. Esmaeli B, Murray JL, Ahmadi MA et al. Immunotherapy for low-grade non-Hodgkin secondary lymphoma of the orbit. Arch Ophthalmol 2002 : 120 : 1225 7.
12. Hambach L, Goulmy E. Immunotherapy of cancer through targeting for minor histocompatibility antigens. Curr Opin Immunol 2005 : 17 : 202 10.
13. Mavromatis B, Cheson BD. Monoclonal antibody therapy of chronic lymphocytic leukemia. J Clin Oncol 2003 : 21 : 1874 81.
14. Jurcic JG. Immunotherapy for acute myeloid leukemia. Curr Oncol Rep 2005 : 7 : 339 46.
15. Robak T. Therapy of chronic lymphocytic leukemia with purine analogs and monoclonal antibodies. Transfus Apher Sci 2005 : 32 : 33 44.
16. Wierda WG, Kipps TJ, Keating MJ. Novel immune-based treatment strategies for chronic lymphocytic leukemia. J Clin Oncol 2005 : 23 : 6325 32.